Convergency LLC, a consulting and advisory firm for pharmaceutical, healthcare, and other heavily-regulated industries, announced an expedited, cloud-based tech approach for companies to effectively deal with pandemics such as the Coronavirus and other emergency situations. Convergency enables a fully operational, 100 percent remote workforce, while sustaining productivity levels, and keeping existing processes in place. Even in today’s lockdown situation, Convergency’s team conducts all project operations off-site from remote locations.
Read More: 7 SalesTech Tools To Fall In Love With!
Convergency Announces Tech and Cloud Measures to help Companies Navigate through the Coronavirus. Provides remote solutions for optimizing cloud deployments and data analytics during crisis situations.
Convergency recently developed a Business Intelligence portal for a global pharmaceutical company, enabling instant sharing of data from 21 clinical trial studies on the COVID-19 epidemic. Convergency enables pharma companies to rapidly adopt new technologies to quickly evaluate the effectiveness of drugs on COVID-19, and other health issues. Its accelerated data analytics process cuts typical delivery times up to 70 percent, while adhering to regulatory and compliance requirements.
“The race to find treatments and possible cures for COVID-19 is in full force. For drug discovery, having timely and relevant data, and seamless data sharing, is a critical part of finding the solution,” said Brian Nigl, CEO of Convergency. “With millions of workers and companies relegated to home offices during this Coronavirus outbreak, and for other future emergency situations, it’s essential that data can be easily shared and made widely available. Companies must build robust, cloud-based systems to account for their workforce being remote.”
Read More: Rising E-Commerce Activities Will Be The Key Driver For Global Cyber Security Market Growth
